Business News • PR NewsWire • BGI and GT Life Sciences, Inc. Report Genome Sequence of CHO-K1 and Provide New Insights into Optimization of Biopharmaceutical Protein Production

BGI and GT Life Sciences, Inc. Report Genome Sequence of CHO-K1 and Provide New Insights into Optimization of Biopharmaceutical Protein Production

BGI and GT Life Sciences, Inc. Report Genome Sequence of CHO-K1 and Provide New Insights into Optimization of Biopharmaceutical Protein Production

SAN DIEGO and SHENZHEN, China, Aug. 1, 2011 /PRNewswire/ -- BGI, the world's largest genomics organization, and GT Life Sciences, Inc., a privately held biotechnology company that utilizes a proven metabolic modeling and experimental platform to drive the discovery and design of new products and pro

View More : http://www.prnewswire.com/news-releases/bgi-and-gt-life-sciences-inc-report-genome-sequence-of-cho-k1-and-provide-new-in...

Releted News by prnewswire

HopFed Bancorp, Inc. Reports Second Quarter Results

NetQin Mobile Names Chris Stier Managing Director for the Americas